Baycol Recall: Example of Poor FDA Regulation
Baycol (cerivastatin-cholesterol lowering) is an example of dangerously poor FDA regulation, according to the testimony of Sidney M. Wolfe, MD Director of the Public Citizen’s Health Research Group (HRG), before the Health Subcommittee of the House Energy and Commerce Committee Hearing on Current Issues Related to Medical Liability Reform on February 10, 2005.
Approximately one year before Baycol was removed from the market in August
2001, its manufacturer Bayer, using FDA data on other statins found that Baycol
had 20 times more reports of rhabdomyolysis (an
often-fatal destruction of muscle) per million prescriptions than Lipitor, Wolfe
stated. An FDA official, feebly excusing FDA’s belated ban, stated that “We
weren’t aware at that point of the difference between Baycol, and the
other similar [drugs]. Our expectation is when a company becomes aware of a
specific problem with their drug, they come to us.” By the time Baycol was
banned, there were 1,899 cases of rhabdomyolysis, a
significant number having occurred between the time there was unequivocal
evidence that FDA should have banned the drug and when it was actually banned a
year later. If you have developed Rhabdomyolysis as result of taking Baycol,
fill out this simple form for a
| Weitz & Luxenberg is no longer accepting Baycol cases. |
|---|
see also:
Baycol
Do you suffer from Rhabdornyolysis because of Baycol (Cerivastatin)Did Cerivastatin/Baycol cause your rhabdornyolysis?Get legal help here
Rhabdomyolysis
Baycol Lawsuit Resources: Baycol Side Effects: RhabdornyolysisBaycol Lawsuit Resources: Baycol Side Effects: Learn about Rhabdornyolysis
Learn More
Rhabdomyolysis, Baycol side effects and other information for a baycol lawsuitAbout Rhabdomyolysis from Baycol - File a Baycol lawsuit with your Baycol lawyer
